| __timestamp | Bausch Health Companies Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 9335772 |
| Thursday, January 1, 2015 | 2682700000 | 12390000 |
| Friday, January 1, 2016 | 2810000000 | 25602000 |
| Sunday, January 1, 2017 | 2582000000 | 21262000 |
| Monday, January 1, 2018 | 2473000000 | 28430000 |
| Tuesday, January 1, 2019 | 2554000000 | 40849000 |
| Wednesday, January 1, 2020 | 2367000000 | 60210000 |
| Friday, January 1, 2021 | 2624000000 | 83664000 |
| Saturday, January 1, 2022 | 2625000000 | 104097000 |
| Sunday, January 1, 2023 | 2917000000 | 106916000 |
Unleashing insights
In the world of pharmaceuticals and biotechnology, managing expenses is crucial for sustainable growth. Bausch Health Companies Inc. and Iovance Biotherapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Bausch Health's Selling, General, and Administrative (SG&A) expenses have shown a steady increase, peaking at nearly 2.9 billion USD in 2023, a 44% rise from 2014. In contrast, Iovance Biotherapeutics, a smaller player, has seen its SG&A expenses grow exponentially, from under 10 million USD in 2014 to over 106 million USD in 2023, marking a staggering 1,038% increase. This divergence highlights the different growth trajectories and strategic priorities of these companies. While Bausch Health focuses on maintaining its market position, Iovance is aggressively investing in its future, reflecting broader industry trends in innovation and expansion.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.
Bausch Health Companies Inc. or Evotec SE: Who Manages SG&A Costs Better?
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?